Heavy Metals in Canadian Legal Cannabis Products Pose Low Health Risk Under Current Regulations

Applying pharmaceutical daily exposure limits to measured metal levels in legal Canadian dried cannabis and vaping liquids showed low risk to health, even for daily or almost-daily consumers at heavy-use levels (95th percentile). The analysis validated that Canada's regulated cannabis supply meets safety standards for elemental impurities.

Risk assessment case study using metal levels measured in legal Canadian cannabis products published by Health Canada. Applied pharmacopoeial permitted daily exposure (PDE) standards. Modeled typical (50th percentile) and heavy (95th percentile) daily use scenarios for inhalation exposure.

Heavy metals in cannabis are a recognized consumer concern, especially for inhaled products. This systematic risk assessment provides the first comprehensive evaluation showing that Canada's regulatory framework -- with good production practices and pharmacopoeial impurity limits -- is effectively controlling this risk.

This study provides a model for other jurisdictions developing cannabis quality standards. The success of Canada's approach suggests that applying pharmaceutical-grade impurity standards to cannabis products is both achievable and effective, though exposure characterization challenges specific to inhalation remain.

Risk assessment is limited to the legal regulated market and does not address illicit products. Uncertainties in exposure characterization for cannabis inhalation (varying amounts consumed, depth of inhalation, frequency) affect precision. The study focuses on elemental impurities only, not other contaminants.